MMP9 and prostate carcinoma: The prostate cancer cells models C4-2/LOX-1(−) and C4-2/LOX-1(+) were incubated with 100 μg/mL oxLDL during 12 hours, and expression of the pro-angiogenic markers (VEGF, MMP-2 and, MMP-9) was analyzed.